These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 33761955)

  • 1. Implications of multiple late gadolinium enhancement lesions on the frequency of left ventricular reverse remodeling and prognosis in patients with non-ischemic cardiomyopathy.
    Ota S; Orii M; Nishiguchi T; Yokoyama M; Matsushita R; Takemoto K; Tanimoto T; Hirata K; Hozumi T; Akasaka T
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):32. PubMed ID: 33761955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
    Kuruvilla S; Adenaw N; Katwal AB; Lipinski MJ; Kramer CM; Salerno M
    Circ Cardiovasc Imaging; 2014 Mar; 7(2):250-258. PubMed ID: 24363358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
    Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
    Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.
    Pöyhönen P; Kivistö S; Holmström M; Hänninen H
    BMC Cardiovasc Disord; 2014 Aug; 14():110. PubMed ID: 25160650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy.
    Wu KC; Weiss RG; Thiemann DR; Kitagawa K; Schmidt A; Dalal D; Lai S; Bluemke DA; Gerstenblith G; Marbán E; Tomaselli GF; Lima JA
    J Am Coll Cardiol; 2008 Jun; 51(25):2414-21. PubMed ID: 18565399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
    Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
    Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy.
    Ehara S; Matsumoto K; Kitada R; Nishimura S; Shimada K; Yoshiyama M
    Heart Vessels; 2018 Dec; 33(12):1482-1489. PubMed ID: 29804280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.
    Kim J; Kochav JD; Gurevich S; Afroz A; Petashnick M; Volo S; Diaz B; Okin PM; Horn E; Devereux RB; Weinsaft JW
    Int J Cardiovasc Imaging; 2014 Dec; 30(8):1559-67. PubMed ID: 25008088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
    Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
    Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
    JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.
    Halliday BP; Gulati A; Ali A; Guha K; Newsome S; Arzanauskaite M; Vassiliou VS; Lota A; Izgi C; Tayal U; Khalique Z; Stirrat C; Auger D; Pareek N; Ismail TF; Rosen SD; Vazir A; Alpendurada F; Gregson J; Frenneaux MP; Cowie MR; Cleland JGF; Cook SA; Pennell DJ; Prasad SK
    Circulation; 2017 May; 135(22):2106-2115. PubMed ID: 28351901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
    Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
    Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic role of late gadolinium enhancement on cardiac magnetic resonance in patients with nonischemic cardiomyopathy and reduced ejection fraction, implanted with cardioverter defibrillators for primary prevention. A systematic review and meta-analysis.
    Anagnostopoulos I; Kousta M; Kossyvakis C; Lakka E; Paraskevaidis NT; Schizas N; Alexopoulos N; Deftereos S; Giannopoulos G
    J Interv Card Electrophysiol; 2022 Apr; 63(3):523-530. PubMed ID: 34218421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Late Gadolinium Enhancement with or Without Reverse Remodeling and Prognosis.
    Kawakami T; Yahagi K; Oshima A; Gonda Y; Yoshiura D; Horiuchi Y; Asami M; Yuzawa H; Komiyama K; Tanaka J; Aoki J; Tanabe K
    Int Heart J; 2024; 65(4):676-683. PubMed ID: 39085108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Late Gadolinium Enhancement in Nonischemic Cardiomyopathy.
    Gaztanaga J; Paruchuri V; Elias E; Wilner J; Islam S; Sawit S; Viles-Gonzalez J; Sanz J; Garcia MJ
    Am J Cardiol; 2016 Oct; 118(7):1063-8. PubMed ID: 27614850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy.
    Barison A; Aimo A; Ortalda A; Todiere G; Grigoratos C; Passino C; Camici PG; Aquaro GD; Emdin M
    Int J Cardiol; 2018 Jan; 250():195-200. PubMed ID: 29107357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does stress perfusion imaging improve the diagnostic accuracy of late gadolinium enhanced cardiac magnetic resonance for establishing the etiology of heart failure?
    Gulsin GS; Shetye A; Khoo J; Swarbrick DJ; Levelt E; Lai FY; Squire IB; Arnold JR; McCann GP
    BMC Cardiovasc Disord; 2017 Apr; 17(1):98. PubMed ID: 28390413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.